OVA G4 peptide
OVA G4 peptide is a variant of the agonist ovalbumin (OVA) peptide SIINFEKL (257-264) . SIINFEKL is routinely used to stimulate ovalbumin-specific T cells and to test new vaccine adjuvants can form a stable hydrogel[1][2].
Product Specifications
CAS Number
148274-82-2
UNSPSC
12352209
Target
Biochemical Assay Reagents
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ova-g4-peptide.html
Solubility
10 mM in DMSO
Smiles
CC(C)C[C@@H](C(O)=O)NC([C@H](CCCCN)NC([C@H](CCC(O)=O)NC([C@H](CC1=CC=CC=C1)NC(CNC([C@H]([C@@H](C)CC)NC([C@H]([C@@H](C)CC)NC([C@H](CO)N)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C43H71N9O12
Molecular Weight
906.08
References & Citations
[1]François P, et al. Phenotypic model for early T-cell activation displaying sensitivity, specificity, and antagonism. Proc Natl Acad Sci U S A. 2013 Mar 5;110 (10) :E888-97.|[2]Kamalov M, et al. Ovalbumin Epitope SIINFEKL Self-Assembles into a Supramolecular Hydrogel. Sci Rep. 2019 Feb 25;9 (1) :2696.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Spiro[3.3]heptan-2-ylmethanamine hydrochloride](https://cdn.genprice.uk/genprice/uk/genprice5.webp)